Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Merck MRK announced that the European Commission (“EC”) has approved its 21-valent pneumococcal conjugate vaccine (“PCV”), Capvaxive, for the prevention of invasive pneumococcal disease ...

Participants were enrolled into one of three cohorts based on their previous pneumococcal vaccination history (cohort 1: PPSV23, cohort 2: PCV13 [pneumococcal 13-valent conjugate vaccine], or ...

Meanwhile, the launch of new-generation innovative products, including the serum-free rabies vaccine, the 13-valent pneumococcal conjugate vaccine, the quadrivalent meningococcal conjugate vaccine ...

No serious adverse events were considered to be related to the study vaccines. Post-dose 3, the VAX-24 Mid dose met target precedent Phase 2 non-inferiority (NI) criteria on relative ...

Pneumococcal conjugate vaccines, including more than seven serotypes, will have potential for a larger effect than PCV7 in many countries, including Norway. A 13-valent pneumococcal conjugate ...

Merck, known as MSD outside of the United States and Canada, announced that the European Commission (EC) has approved Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) for active immunization for ...

Get Instant Summarized Text (Gist) Coverage for routine childhood vaccines, including rotavirus, diphtheria, tetanus, acellular pertussis, and pneumococcal conjugate, remains below prepandemic ...

Applied in a vaccination program, the 7-valent pneumococcal conjugate vaccine (PCV7) in a 2+1 dose schedule appears to be highly effective. Conjugate vaccines with more than seven serotypes will ...

and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine). in February 2025, the US Food and Drug Administration approved GSK's MenABCWY vaccine for use in individuals aged 10 through 25 years.